General Information of the Compound
| Compound ID |
CP0751988
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
SID50106461
Show/Hide
|
||||||||||||||||||
| Synonyms |
(+/-)-Idazoxan Monohydrochloride
1H-Imidazole, 2-(2,3-d
1H-Imidazole, 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-,monohydrochloride
79944-56-2
AC1L4CEL
AKOS024458652
BN0267
CCG-214002
CHEMBL543467
CTK8G0263
HMS1570J14
IDAZOXAN HYDROCHLORIDE
Idazoxan (hydrochloride)
Idazoxan HCl
LP00652
MFCD00069293
MLS000069708
MLS001148081
MYUBYOVCLMEAOH-UHFFFAOYSA-N
MolPort-003-941-824
NSC-759867
NSC759867
Opera_ID_847
Pharmakon1600-01506073
RX 781094
RX 781094A
SCHEMBL707367
SMR000058458
SR-01000000206
Tox21_500652
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H13ClN2O2
|
||||||||||||||||||
| Molecular Weight |
240.69
|
||||||||||||||||||
| Canonical SMILES |
Cl.c1ccc2c(c1)OCC(C1=NCCN1)O2
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H12N2O2.ClH/c1-2-4-9-8(3-1)14-7-10(15-9)11-12-5-6-13-11;/h1-4,10H,5-7H2,(H,12,13);1H
Show/Hide
|
||||||||||||||||||
| InChIKey |
MYUBYOVCLMEAOH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound